American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
- PMID: 20539732
- PMCID: PMC2805345
- DOI: 10.1200/JOP.091065
American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non-Small-Cell Lung Cancer
Abstract
ASCO published a guideline on use of chemotherapy in advanced stage non-small-cell lung cancer in 1997. The latest update covers treatment with chemotherapy and biologic agents and reviews literature from 2002 to 2009.
References
-
- American Society of Clinical Oncology. Clinical practice guidelines for the treatment of unresectable non–small-cell lung cancer: Adopted on May 16, 1997, by the American Society of Clinical Oncology. J Clin Oncol. 1997;15:2996–3018. - PubMed
-
- Pfister DG, Johnson DH, Azzoli CG, et al. American Society of Clinical Oncology treatment of unresectable non–small-cell lung cancer guideline: Update 2003. J Clin Oncol. 2004;22:330–353. - PubMed
-
- Azzoli CG, Baker S, Jr, Temin S, et al. American Society of Clinical Oncology Clinical Practice Guideline Update on Chemotherapy for Stage IV Non–Small-Cell Lung Cancer. J Clin Oncol. doi: 10.1200/JCO.2009.23.5622. - DOI - PMC - PubMed
-
- US Food and Drug Administration. FDA alert for health care professionals: Gefitinib (marked as Iressa) http://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInform....
-
- Canadian Agency for Drugs and Technologies in Health. Gefitinib. http://www.cadth.ca/index.php/en/cdr/search/?&status=all&keywords=gefitinib. - PubMed
LinkOut - more resources
Full Text Sources